ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0948

ANCA Positivity Is Associated with a Necrotizing and Crescentic Phenotype in Pediatric Patients with Lupus Nephritis: A Chinese Cohort Study

Session Information

Category: Pediatric Nephrology

  • 1800 Pediatric Nephrology

Authors

  • He, Jia, Shanghai Children's Medical Center Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China
  • Yin, Lei, Shanghai Children's Medical Center Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China
  • Pan, Xiaoxia, Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, Shanghai, China
  • Xu, Jing, Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, Shanghai, China
Background

ANCA positivity has been described in lupus nephritis (LN). Limited evidence suggests ANCA-positive LN in adults may carry more severe necrotizing and crescentic lesions,but its clinical and pathologic significance in pediatric populations is poorly defined.

Methods

We retrospectively studied 110 pediatric LN cases (2016–2025). Serum ANCA was tested by indirect immunofluorescence. Clinicopathologic features and short-term renal outcomes were compared between ANCA-positive (ANCA+) and ANCA-negative (ANCA−) groups. Within ANCA+ cases, an AAV-like LN phenotype was defined a priori as ≥2 of: crescents >15%, segmental fibrinoid necrosis, thrombotic microangiopathy, or systemic vasculitic features.

Results

Of 110 patients, 67 (61%) were ANCA+ (66 P-ANCA, 1 C-ANCA). Compared with ANCA−, ANCA+ cases showed higher SLEDAI, more pulmonary involvement, lower C3/C4, enriched positive anti-dsDNA, and significant excesses of cellular/fibrocellular crescents and fibrinoid necrosis despite comparable ISN/RPS class distribution. Twenty-six ANCA+ patients (38.8%) met AAV-like phenotype criteria, exhibiting more interstitial inflammation but fewer wire-loop lesions and weaker C1q deposition — a partial pauci-immune profile, alongside impaired baseline renal function and lower one-year LN remission (Table1).

Conclusion

The AAV-like phenotype in pediatric ANCA+ LN combines severe necrotizing/crescentic injury and TMA with reduced classical immune-complex features (less wire-loop, lower heavy C1q), higher disease activity, impaired baseline renal function, and worse one-year LN remission — defining an overlap phenotype that argues for routine ANCA testing as a risk-stratification tool in pediatric LN.

Acknowledgment

We are grateful to Professor Anthony Chang from University of Chicago for his valuable insights and constructive suggestions that improved this work. We also would like to thank the pediatric rheumatology specialists at the Department of Rheumatology and Immunology, Shanghai Children’s Medical Center, for providing partial data on pediatric lupus patients and supporting this study.

Table 1. Pathologic and outcome contrast within ANCA-positive pediatric LN: AAV-like phenotype vs. non-AAV-like.

Funding

  • Government Support – Non-U.S.